| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 13, 2006
Accepted on July 5, 2006
University of Michigan, Department of Epidemiology, School of Public Health, Ann Arbor, Michigan, USA; University of Michigan, Department of Obstetrics and Gynecology, Ann Arbor, Michigan, USA; University of Michigan, Department of Biostatistics, School of Public Health, Ann Arbor, Michigan, USA
* To whom correspondence should be addressed. E-mail: mfsowers{at}umich.edu.
Objective and Context: To determine if luteal abnormalities or measures of sex steroid hormones collected across a menstrual cycle were associated with bone mineral density (BMD) at the total hip or lumbar spine.
Design and Setting: The Study of Women's Health Across the Nation (SWAN) is a longitudinal, community-based study conducted at seven clinical sites. SWAN includes a Daily Hormone Study sub-study in which daily urine samples are collected for one menstrual cycle (up to a maximum of 50 days) each year.
Participants: 643 pre- and peri-menopausal women, aged 43-53 yr.
Main Outcome Measures: BMD of the lumbar spine and total hip was measured by dual energy x-ray densitometry. Daily urine samples were assayed for estrone conjugates (uE1C), pregnanediol glucuronide (uPdG), LH (uLH), and follicle-stimulating hormone (uFSH) and the information from across the menstrual cycle expressed as area under the curve (AUC). BMD levels were evaluated in relation to three menstrual cycle attributes: (1) absence or presence of ovulation; (2) luteal phase length to menstrual cycle length ratio; and (3) ovulatory disturbances, defined as anovulatory cycles or cycles with short luteal phases (<10 days).
Results: Lower uE1C AUC and higher uFSH AUC were significantly associated with lower BMD. However, luteal abnormalities based on menstrual cycle attributes were not significantly associated with BMD at the total hip or lumbar spine, following adjustment for age, BMI, urinary hormone concentrations, menopausal status, and race/ethnicity.
Conclusions: Direct measures of urinary hormones, not menstrual cycle luteal abnormalities, were associated with lower levels of BMD.
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |